HOME - Companies - Products
 
 
18 February 2026

ORCA Dental Kit Secures Vizient Recognition


ORCA Products announced its ORCA Dental Emergency Pain Kit has received an Innovative Technology contract from Vizient®, the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded based on a review of the ORCA Dental Emergency Pain Kit by hospital experts who serve on one of Vizient’s client-led councils, and it signifies to Vizient clients its unique qualities that potentially bring improvement to the healthcare industry.

Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program. Vizient client-led councils identify technologies that have the potential to enhance clinical care, patient safety, healthcare worker safety, or improve business operations of healthcare organizations.

“We are honored to receive this recognition from Vizient,” said Dr. Craig Schmidtke, CEO of ORCA Products. “The ORCA Dental Emergency Pain Kit is the first solution of its kind for urgent care and ER settings. Together, its components provide rapid, localized relief for patients, help clinicians reduce reliance on opioids—supporting efforts to address the opioid crisis on the front lines of care—and give the entire healthcare team peace of mind in situations where no effective solution previously existed.”

The ORCA Dental Emergency Pain Kit is a multi-component, non-opioid solution designed for managing dental pain in emergency departments and urgent care settings. The kit includes ORCA Foam, an absorbable hemostatic gelatin sponge used as a carrier for ORCA Complete Dry Socket Solution to address unattended post-operative discomfort, along with ORCA Pain Relief Putty, a patented topical natural formulation that adheres in place to target toothaches and oral pain.

“After a review of the ORCA Dental Emergency Pain Kit, Vizient’s client-led council agreed this technology offers a unique benefit over other products available in the market today and recommended it for an Innovative Technology contract. We are pleased to award this new contract to ORCA Products,” said Kelly Flaharty, associate vice president, contract operations for Vizient.

Vizient represents a diverse client base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute healthcare providers, and has a portfolio that represents more than $156 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with client-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare. If it is determined that a product is innovative, Vizient may award a contract outside of the competitive bid cycle.

ORCA Products, LLC is a U.S.-based medical device company focused on innovative, non-opioid solutions for dental pain management and hemostasis in ambulatory surgery settings. Best known as the gold-standard treatment for toothaches and dry sockets, ORCA delivers safe, effective products that fill critical gaps in emergency and urgent care while improving patient outcomes across medical and dental continuums of care.


Source: https://www.vizientinc.com/

Related articles

The presence of the mandibular incisor canal in the anterior mandibular region requires particular attention in implant surgery, during autogenous bone harvesting, genioplasty and fracture surgery.


By Columbia University CDM News

Dr. Fatemeh Momen-Heravi, DDS, an associate professor at the Columbia University College of Dental Medicine, has identified a number of genomic alterations and molecular signatures in head and neck...


Market analysts, Grand View Research, Inc., forecast that the dental caries detector market will attain a value of $512.0 million by 2028. The growth would mark a CAGR of 8.9% during the reporting...


Co-authors: Roberto Spreafico, Franco Brenna, Cesare Robello, Massimo Nuvina, Massimo Mario Gagliani

The aim of this study is to pro- pose an update on ceramics for partial and total indirect reconstructions performed with CAD/ CAM. MATERIALS AND METHODS Through a careful study of...


Dental caries is one the most prevalent chronic disease in the world. It affects 60% to 90% of children and a large part of the adult population (data of the...


Read more

New initiative invites dentists to experience DEXIS’ most advanced AI yet, built on scale, speed, and clinical trust.


(Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/C


(Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected Will


As the University of Colorado School of Dental Medicine celebrates the graduating DDS Class of 2025, we are proud to recognize the students and faculty members whose exceptional de


This peer-reviewed oral surgery article summarizes clinical evidence from International journal of oral and maxillofacial surgery (2026). It focuses on findings that may help dental professionals...


 
 
 
 

 
 
 
 

Most popular

 
 

Events